Human Glucose Transporter GLUT1 peptide (ab115830)



  • NatureSynthetic
  • Amino Acid Sequence
    • SpeciesHuman
    • Amino acids478 to 492

Associated products


Our Abpromise guarantee covers the use of ab115830 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking - Blocking peptide for Anti-Glucose Transporter GLUT1 antibody (ab652)

  • FormLiquid
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

    Constituent: dH2O

General Info

  • Alternative names
    • Choreoathetosis/spasticity episodic (paroxysmal choreoathetosis/spasticity)
    • CSE
    • DYT17
    • DYT18
    • DYT9
    • EIG12
    • erythrocyte/brain
    • Erythrocyte/hepatoma glucose transporter
    • facilitated glucose transporter member 1
    • Glucose transporter 1
    • Glucose transporter type 1
    • Glucose transporter type 1, erythrocyte/brain
    • GLUT
    • GLUT-1
    • GLUT1
    • GLUT1DS
    • GLUTB
    • GT1
    • GTG1
    • Gtg3
    • GTR1_HUMAN
    • HepG2 glucose transporter
    • HTLVR
    • Human T cell leukemia virus (I and II) receptor
    • MGC141895
    • MGC141896
    • PED
    • RATGTG1
    • Receptor for HTLV 1 and HTLV 2
    • SLC2A1
    • Solute carrier family 2
    • Solute carrier family 2 (facilitated glucose transporter), member 1
    • Solute carrier family 2, facilitated glucose transporter member 1
    see all
  • FunctionFacilitative glucose transporter. This isoform may be responsible for constitutive or basal glucose uptake. Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses.
  • Tissue specificityExpressed at variable levels in many human tissues.
  • Involvement in diseaseDefects in SLC2A1 are the cause of glucose transporter type 1 deficiency syndrome (GLUT1DS) [MIM:606777]; also known as blood-brain barrier glucose transport defect. This disease causes a defect in glucose transport across the blood-brain barrier. It is characterized by infantile seizures, delayed development, and acquired microcephaly.
    Defects in SLC2A1 are the cause of dystonia type 18 (DYT18) [MIM:612126]. DYT18 is an exercise-induced paroxysmal dystonia/dyskinesia. Dystonia is defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. DYT18 is characterized by attacks of involuntary movements triggered by certain stimuli such as sudden movement or prolonged exercise. In some patients involuntary exertion-induced dystonic, choreoathetotic, and ballistic movements may be associated with macrocytic hemolytic anemia.
  • Sequence similaritiesBelongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. Glucose transporter subfamily.
  • Post-translational
    Phosphorylated upon DNA damage, probably by ATM or ATR.
  • Cellular localizationCell membrane. Melanosome. Localizes primarily at the cell surface (By similarity). Identified by mass spectrometry in melanosome fractions from stage I to stage IV.
  • Information by UniProt

References for Human Glucose Transporter GLUT1 peptide (ab115830)

ab115830 has not yet been referenced specifically in any publications.

Product Wall

Thank you for contacting us. I can finally confirm that the peptide products are now available on our website. Peptide for ab652 = ab115830 Peptide for ab654 = ab115831 I hope this information is helpful to you. Please do not ...

Read More